In three previous blog posts, we have discussed recent inventorship issues surrounding Artificial Intelligence (“AI”) and its implications for life sciences innovations – focusing specifically on scientist Stephen Thaler’s attempt to obtain a patent for an invention created by his AI system called DABUS (“Device for Autonomus Bootstrapping of Unified Sentence). Most recently, we considered Thaler’s appeal of the September 3, 2021 decision out of the Eastern District of Virginia, which ruled that under the Patent Act, an AI machine cannot qualify as an “inventor.” Continuing this series, we now consider the USPTO’s recently filed opposition to Thaler’s appeal.

In its opposition brief, the USPTO argued that under the “plain language Congress chose to incorporate in the Patent Act,” only a human being can be considered an “inventor.” The USPTO first noted that the definitions of “inventor” and “joint inventor” under the Patent Act both unequivocally refer only to an “individual” or “individuals.” For example, “inventor” is defined under the Act as “the individual or, if a joint invention, the individuals collectively who invented or discovered the subject matter of the invention.”

While the Patent Act does not explicitly define the term “individual,” the USPTO argued that in other instances where the term is not explicitly defined, courts have interpreted Congress’s use of the term “individual” in a given statute as denoting a “human being,” as opposed to other things. The USPTO provided the example of Mohamad v. Palestinian Auth., a 2012 case in which the Supreme Court evaluated whether Congress’s use of the term “individual in the Torture Victim Protection Act (“TVPA”) could be construed to include an “organization.” There, the Court quoted from several well-known dictionaries and considered the use of the term in “everyday parlance,” to determine that the ordinary meaning of the term “individual” refers only to a human being or natural person. The Court in Mohamad also referred to the Dictionary Act, 1 U.S.C. § 1, which provides that the legislative use of the term “individual” denotes something separate and apart from non-human beings.

The USPTO argued that the Supreme Court’s analysis in Mohamad is equally applicable to the Patent Act as it is to the TVPA. For example, the term “individual” is used in the Patent Act as a noun, just as it is in the TVPA. And, according to the USPTO, just as the Mohamad Court recognized “no one…refers in normal parlance to an organization as an ‘individual,’” it is equally true that “no one… refers in normal parlance” to a machine or collection of source code as an “individual.” Further, the USPTO pointed out that the Dictionary Act applies not only to the TVPA, but to all congressional enactments – including the Patent Act.

Though the Supreme Court’s opinion in Mohamad acknowledges that Congress is free to give the term “individual” a “broader or different meaning,” such “broader” construction by a court requires some affirmative “indication [that Congress] intended such a result.” Here, the USPTO argues that Thaler has never pointed to any textual evidence that Congress intended a broader meaning for the term. The USPTO argues that Thaler has only put forth non-textual policy arguments. For example, Thaler argues that denying inventorship to AI would place the United States behind “other countries [that] are promoting the progress of science,” and would amount to “adopt[ing] luddism.” However, according to the USPTO, these policy considerations cannot overcome the plain meaning of the text.

We will continue to monitor this appeal, as it has important implications for life sciences companies employing AI technologies, particularly given the low probability that Congress will act on this issue in the short term.

Photo of Anisha Shenai-Khatkhate Anisha Shenai-Khatkhate

Anisha Shenai-Khatkhate is an associate in the Litigation Department. She is a commercial litigator with a particular emphasis on false advertising and consumer class actions, copyright disputes, and related intellectual property litigation. Anisha has experience representing and advising clients in a wide array…

Anisha Shenai-Khatkhate is an associate in the Litigation Department. She is a commercial litigator with a particular emphasis on false advertising and consumer class actions, copyright disputes, and related intellectual property litigation. Anisha has experience representing and advising clients in a wide array of industries including consumer products, music and entertainment, publishing, telecommunications, fashion and sports.

Anisha is an editor of and a frequent author for Proskauer’s advertising law blog, Proskauer on Advertising.

Prior to joining Proskauer, Anisha earned a B.A. in Neurobiology from Harvard University, and J.D. from Columbia Law School. While at Columbia, Anisha interned at Volunteer Lawyers for the Arts, helping to provide pro bono legal services to New York artists and arts organizations. She also served as an articles editor of the Columbia Science and Technology Law Review, and was the recipient of Columbia Law School’s Emil Schlesinger Labor Law Prize, awarded annually to the student most proficient in the subject of labor law.

Photo of Baldassare Vinti Baldassare Vinti

Baldassare Vinti is a partner in the Patent Law and Intellectual Property Groups.

Baldo’s practice focuses on litigating patent, false advertising, trade secret, trademark and contractual matters in federal and state courts and before the International Trade Commission. He is a skilled intellectual…

Baldassare Vinti is a partner in the Patent Law and Intellectual Property Groups.

Baldo’s practice focuses on litigating patent, false advertising, trade secret, trademark and contractual matters in federal and state courts and before the International Trade Commission. He is a skilled intellectual property litigator with extensive experience in all aspects of litigation, including trials (jury and bench), Markman hearings, appeals before the Federal Circuit, case preparation and strategy, depositions, motion practice, and settlement negotiations. In the area of patent litigation, he has worked on cases involving a broad range of technologies, including medical devices, diagnostics, immunoassays, orthotics and prosthetics, proton pump inhibitor pharmaceuticals, dental implants, electronic medical records systems, wound dressings, pharmaceutical capsules, digital video compression, electronic book delivery and security systems, mobile phones and mobile media technologies, ATSC digital television standard, navigation, location-based services, bandwidth management, bar code scanning, irrigation equipment, waste management systems, laser inscription devices, and other related technologies. Baldo has represented numerous major corporations in patent litigations, including British Telecommunications PLC, Church & Dwight Co., Inc., Henry Schein, Inc., Maidenform Brands Inc., Mitsubishi Electric Corp., Ossur North America Inc., Panasonic Corp., Sony Corp., U.S. Philips Corp. and Zenith Electronics LLC.